View in EDS HTML Full Text PDF Full Text

MicroRNAs as Regulators of Neuroinflammation in Major Depressive Disorder.

Saved in:
Bibliographic Details
Title: MicroRNAs as Regulators of Neuroinflammation in Major Depressive Disorder.
Authors: Li, Qirui (AUTHOR), Ling, Yuyan (AUTHOR), Gu, Ling (AUTHOR), Li, Lei (AUTHOR), Liu, Yutong (AUTHOR), Ma, Yuanyuan (AUTHOR), Ma, Ruiting (AUTHOR), Chen, Meijuan (AUTHOR), Asif, Muhammad (AUTHOR)
Source: Depression & Anxiety (1091-4269). 12/11/2025, Vol. 2025, p1-20. 20p.
Subjects: MicroRNA, Neuroinflammation, Blood-brain barrier, Drug target, Cytokines, Neuroplasticity, Bioactive compounds, Mental depression
Abstract: Major depressive disorder (MDD) is a globally prevalent mental health condition with a complex pathogenesis and substantial disease burden. However, due to incomplete mechanistic understanding, existing therapeutic strategies frequently yield suboptimal outcomes. This review synthesizes evidence establishing neuroinflammation as a central pathogenic mechanism of MDD, involving elevated proinflammatory cytokines, microglial M1 polarization, blood–brain barrier (BBB) disruption, hypothalamic–pituitary–adrenal (HPA) axis dysregulation, and impaired neuroplasticity. Micro ribonucleic acid (miRNA) are identified as master molecular regulators bridging neuroinflammation and MDD pathology with details of how specific dysregulated miRNAs orchestrate MDD processes by targeting key inflammatory pathways, directing microglial polarization states, mediating intercellular communication via exosomes, and modulating BBB integrity. Crucially, these miRNAs may serve as novel diagnostic biomarkers and therapeutic targets for MDD. Building on this, we explore the potential of natural compounds as innovative miRNA‐targeting therapeutics that can ameliorate neuroinflammation and restore neuroplasticity. Current challenges relating to clinical translation are discussed, including discordance between peripheral and brain miRNA profiles, species‐specific miRNA functional variations, limited biomarker specificity across psychiatric disorders, the absence of standardized clinical reference ranges, and the need for more effective delivery systems. Overall, this review positions miRNA‐mediated neuroinflammation regulation as a transformative frontier for MDD pathogenesis research and targeted treatment. [ABSTRACT FROM AUTHOR]
Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 190212483
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MicroRNAs as Regulators of Neuroinflammation in Major Depressive Disorder.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Li%2C+Qirui%22">Li, Qirui</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ling%2C+Yuyan%22">Ling, Yuyan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gu%2C+Ling%22">Gu, Ling</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Lei%22">Li, Lei</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yutong%22">Liu, Yutong</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Yuanyuan%22">Ma, Yuanyuan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Ruiting%22">Ma, Ruiting</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Meijuan%22">Chen, Meijuan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Asif%2C+Muhammad%22">Asif, Muhammad</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Depression+%26+Anxiety+%281091-4269%29%22">Depression & Anxiety (1091-4269)</searchLink>. 12/11/2025, Vol. 2025, p1-20. 20p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22MicroRNA%22">MicroRNA</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroinflammation%22">Neuroinflammation</searchLink><br /><searchLink fieldCode="DE" term="%22Blood-brain+barrier%22">Blood-brain barrier</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+target%22">Drug target</searchLink><br /><searchLink fieldCode="DE" term="%22Cytokines%22">Cytokines</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroplasticity%22">Neuroplasticity</searchLink><br /><searchLink fieldCode="DE" term="%22Bioactive+compounds%22">Bioactive compounds</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Major depressive disorder (MDD) is a globally prevalent mental health condition with a complex pathogenesis and substantial disease burden. However, due to incomplete mechanistic understanding, existing therapeutic strategies frequently yield suboptimal outcomes. This review synthesizes evidence establishing neuroinflammation as a central pathogenic mechanism of MDD, involving elevated proinflammatory cytokines, microglial M1 polarization, blood–brain barrier (BBB) disruption, hypothalamic–pituitary–adrenal (HPA) axis dysregulation, and impaired neuroplasticity. Micro ribonucleic acid (miRNA) are identified as master molecular regulators bridging neuroinflammation and MDD pathology with details of how specific dysregulated miRNAs orchestrate MDD processes by targeting key inflammatory pathways, directing microglial polarization states, mediating intercellular communication via exosomes, and modulating BBB integrity. Crucially, these miRNAs may serve as novel diagnostic biomarkers and therapeutic targets for MDD. Building on this, we explore the potential of natural compounds as innovative miRNA‐targeting therapeutics that can ameliorate neuroinflammation and restore neuroplasticity. Current challenges relating to clinical translation are discussed, including discordance between peripheral and brain miRNA profiles, species‐specific miRNA functional variations, limited biomarker specificity across psychiatric disorders, the absence of standardized clinical reference ranges, and the need for more effective delivery systems. Overall, this review positions miRNA‐mediated neuroinflammation regulation as a transformative frontier for MDD pathogenesis research and targeted treatment. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=190212483
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1155/da/9984291
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 20
        StartPage: 1
    Subjects:
      – SubjectFull: MicroRNA
        Type: general
      – SubjectFull: Neuroinflammation
        Type: general
      – SubjectFull: Blood-brain barrier
        Type: general
      – SubjectFull: Drug target
        Type: general
      – SubjectFull: Cytokines
        Type: general
      – SubjectFull: Neuroplasticity
        Type: general
      – SubjectFull: Bioactive compounds
        Type: general
      – SubjectFull: Mental depression
        Type: general
    Titles:
      – TitleFull: MicroRNAs as Regulators of Neuroinflammation in Major Depressive Disorder.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li, Qirui
      – PersonEntity:
          Name:
            NameFull: Ling, Yuyan
      – PersonEntity:
          Name:
            NameFull: Gu, Ling
      – PersonEntity:
          Name:
            NameFull: Li, Lei
      – PersonEntity:
          Name:
            NameFull: Liu, Yutong
      – PersonEntity:
          Name:
            NameFull: Ma, Yuanyuan
      – PersonEntity:
          Name:
            NameFull: Ma, Ruiting
      – PersonEntity:
          Name:
            NameFull: Chen, Meijuan
      – PersonEntity:
          Name:
            NameFull: Asif, Muhammad
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 12
              Text: 12/11/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 10914269
          Numbering:
            – Type: volume
              Value: 2025
          Titles:
            – TitleFull: Depression & Anxiety (1091-4269)
              Type: main
ResultId 1